Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
432P Hydrogen sulfide attenuates skeletal muscle abnormalities in a murine model of Duchenne muscular dystrophy — Agnieszka Łoboda (2024) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
432P Hydrogen sulfide attenuates skeletal muscle abnormalities in a murine model of Duchenne muscular dystrophy
Shared by
Jozef Dulak
Jagiellonian University Cracow
432P Hydrogen sulfide attenuates skeletal muscle abnormalities in a murine model of Duchenne muscular dystrophy
Article
2024
en
Authors
+4 more
AŁ
Agnieszka Łoboda
MM
Małgorzata Myszka
OM
Olga Mucha
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2022
Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases
Katarzyna Kaziród
,
Małgorzata Myszka
,
Jozef Dulak
,
Agnieszka Łoboda
Article
2021
Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy
Olga Mucha
,
Paulina Podkalicka
,
Katarzyna Kaziród
,
Emilia Samborowska
,
Jozef Dulak
,
Agnieszka Łoboda
Article
2024
Cardioprotective Effects of Hydrogen Sulfide and Its Potential Therapeutic Implications in the Amelioration of Duchenne Muscular Dystrophy Cardiomyopathy
Agnieszka Łoboda
,
Jozef Dulak
Article
2019
Targeting angiogenesis in Duchenne muscular dystrophy
Paulina Podkalicka
,
Olga Mucha
,
Jozef Dulak
,
Agnieszka Łoboda
Preprint
2021
Simvastatin Influences Selected Aspects of Duchenne Muscular Dystrophy Pathology in a Mouse Model
Olga Mucha
,
Paulina Podkalicka
,
Katarzyna Kaziród
,
Jozef Dulak
,
Agnieszka Łoboda
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.